Aspergillus flavus sinusitis in ALL

Am J Hematol. 2009 Feb;84(2):123. doi: 10.1002/ajh.21167.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / drug therapy
  • Aspergillosis / etiology
  • Aspergillosis / microbiology*
  • Aspergillosis / surgery
  • Aspergillus flavus / isolation & purification*
  • Caspofungin
  • Combined Modality Therapy
  • Debridement
  • Drug Therapy, Combination
  • Echinocandins / therapeutic use
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunocompromised Host
  • Lipopeptides
  • Neutropenia / chemically induced
  • Neutropenia / complications
  • Neutropenia / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Sinusitis / diagnosis
  • Sinusitis / drug therapy
  • Sinusitis / etiology
  • Sinusitis / microbiology*
  • Sinusitis / surgery

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • liposomal amphotericin B
  • Granulocyte Colony-Stimulating Factor
  • Amphotericin B
  • Caspofungin